Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomerâ„¢ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks. Show more Show less
$30M sweet spot round size
1983
$30M
from 2 investors over 1 rounds
Heron Therapeutics, Inc. raised $30M on August 24, 2023
Investors: Rubric Capital Management and + 2 Other investors